Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/2/26 19:33 | 8/26/26 | EXOZ | Health | BioPrd | Biological Products, (No Diag | Heltzen Michael | CA | O | CEO | P.m | 6 | 7.49 | 0 | 1 | 7 | 14 | D | ||||||||||||||
8/25/26 19:16 | 8/19/26 | EXOZ | Health | BioPrd | Biological Products, (No Diag | Perriman Damien Alan | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 20 | 221 | 28 | D | ||||||||||||||
8/25/26 18:57 | 8/19/26 | EXOZ | Health | BioPrd | Biological Products, (No Diag | Korman Tyler Paz | CA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 33 | 5 | 763 | D | ||||||||||||||
4/10/26 16:30 | 4/8/26 | EXOZ | Health | BioPrd | Biological Products, (No Diag | Korman Tyler Paz | CA | O | Chief Sc | S.m | -15 | 10.28 | 0 | -2 | 0 | 729 | D | ||||||||||||||
7/2/25 17:49 | 7/2/25 | EXOZ | Health | BioPrd | Biological Products, (No Diag | Heltzen Michael | CA | O | CEO | P | 11 | 10.22 | 0 | 1 | 11 | 11 | D | ||||||||||||||
1/21/25 06:02 | 1/16/25 | IZTC | Health | BioPrd | Biological Products, (No Diag | Heltzen Michael | CA | O | CEO | P.m | 20 | 10.78 | 0 | 2 | 95 | 4 | D | ||||||||||||||
11/19/24 18:45 | 11/15/24 | IZTC | Health | BioPrd | Biological Products, (No Diag | Heltzen Michael | CA | O | CEO | P | 22 | 11.10 | 0 | 2 | New | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |